The EULAR 2015 Report - Thursday
These abstracts and presentations were presented Thursday 11 June at the EULAR 2015 annual meeting.
News
EULAR Recommendations on Imaging for SpA
A EULAR task force of 21 rheumatologists and radiologists from 11 countries examined 12 clinical/imaging questions and reviewed the literature to establish consensus on imaging for spondyloarthritis in practice.
The EULAR 2015 Report - Wednesday
EULAR 2015 started the afternoon of Wednesday June 10th.
Rheumatic Manifestations of Chikungunya Virus
Chikungunya is a new viral cause of fever and arthritis, especially in endemic areas like the caribbean. The chikungunya epidemic has grown significantly in the Western hemisphere with a total of 1,247,000 cases and 183 fatalities since
Is Ultrasound Changing Rheumatology Practice?
The recent inclusion of ultrasound in the classification criteria of various rheumatic diseases, such as polymyalgia rheumatica and gout, implies this imaging technique is not onlyuseful as a valued diagnostic tool for individual cases, but also on a larger scale, it will improve doctors' ability to
Allopurinol Reduces Mortality in Gout
CVD risk is significantly augmented in gout. Choi and coworkers studied this issue using a UK general population database using an incident user cohort study with propensity score matching.
Does Cirrhosis Increase the Risk of Autoimmune Disorders?
A Danish nationwide healthcare registry was used to identify newly diagnosed alcoholic cirrhosis patients between 1977 and 2010. A matched cohort analysis compared each patient with five random individuals from the population.
High Flare Rates with Drug Withdrawal in JIA
While many adult rheumatologists are able to lessen or withdraw DMARD and biologic therapy in adults, little is known about the success of this practice in pediatric rheumatology clinics.
Knee Implant Forecast from 2012 - 2018
The global knee implants market was USD 8.4 billion in 2011, and it's forecasted to reach USD 15 billion in 2018, with compound annual growth rate of 8.64% during 2011 to 2018. The U.S.
Difficulties Diagnosing Interstitial Lung Disease in Scleroderma
The diagnosis of chronic lung disease in patients with systemic sclerosis may be difficult because of atypical symptoms, variable evolution and limitations of current classification criteria for a definite diagnosis. Nevertheless, diagnosis is necessary as patients with SSc-ILD have a p
Tofacitinib Equal to Etanercept in Psoriasis, but only at 10 mg bid Dose
A 12-week, phase III, non-inferiority, randomized clinical trial of tofacitinib, etanercept or placebo was conducted in 1106 patients with plaque psoriasis.
Comorbidities Increasing in Arthritis Patients
A CDC report shows comorbid conditions exist in 73.1% of all arthritis patients. Based on NHIS survey data, the number of patients with 2 or more comorbid conditions has increased from 21.8% in 2001 to 25.5% in 2012. Most affected were older adults (≥65 years), women, wh
Eczema associated with osteoporosis and fractures
NHANES data shows eczema is associated with a higher rate of fractures and osteoporosis. Of the nearly 5,000 people included in the study, seven percent reported a diagnosis of eczema.
Safety of Azathioprine in SLE Pregnancy Studied
Saavedrra and coworkers studied 178 lupus pregnancies and compared outcomes in the 87 azathioprine exposed compared to the 91 who were not exposed. There were no differences between groups with regard to fetal outcomes. No major congenital malformatons were noted.
Will legislation change copays?
Dr. Angus Worthing writes of patient angst over rising copays. Expensive specialty medications are the frequent target of "sharing" the rising costs of medications and making them the patients responsibility and not the insurers.
